fleroxacin has been researched along with Infection, Wound in 1 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most common diagnoses were wound infections and cellulitis, which affected 36% and 30% of the fleroxacin group, and 24% and 24% of the ceftazidime group, respectively." | 2.67 | Systemic antimicrobial therapy for skin and skin structure infections: comparison of fleroxacin and ceftazidime. ( Jungkind, DL; Parish, LC, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parish, LC | 1 |
| Jungkind, DL | 1 |
1 trial available for fleroxacin and Infection, Wound
| Article | Year |
|---|---|
Systemic antimicrobial therapy for skin and skin structure infections: comparison of fleroxacin and ceftazidime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Ceftazidime; Cellulitis; Female; Fleroxacin; H | 1993 |